The research suggests that in mice with Alzheimer's disease certain immune cells that normally protect the brain begin abnormally to consume an important nutrient called arginine.
By blocking this process using the drug difluoromethylornithine (DFMO), memory loss and a buildup of sticky proteins known as brain plaques were prevented.